Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

One of the oddest ways that an AI system can fail is by falling prey to an adversarial attack — a cleverly manipulated input that makes the system behave in an unexpected way.

Why it matters: Autonomous car experts worry that their cameras are susceptible to these tricks: It's been shown that a few plain stickers can make a stop sign look like a "Speed Limit 100" marker to a driverless vehicle. But other high-stakes fields — like medicine — are paying too little attention to this risk.

That's according to a powerhouse of researchers from Harvard and MIT, who published an today article in Science arguing that these attacks could blindside hospitals, pharma companies, and big insurers.

Details: Consider a photo of a mole on a patient's skin. Research has shown that it can be manipulated in a way that's invisible to the human eye, but still changes the result of an AI system's diagnosis from cancerous to non-cancerous.

The big question: Why would anyone want to do this?

  • For Samuel Finlayson, an MD–PhD candidate at Harvard and MIT and the lead author of the new paper, it’s a question of incentives. If someone sending in data for analysis has a different goal than the owner of the system doing the analysis, there's a potential for funny business.
  • We're not talking about a malicious doctor manipulating cancer diagnoses — "There's way more effective ways to kill a person," Finlayson says — but rather an extension of existing dynamics into a near future where AI is involved in billing, diagnosis, and reading medical scans.

Doctors and hospitals already game the insurance billing system — these could be considered proto-adversarial attacks, Finlayson tells Axios.

  • They often bill for more expensive procedures than they performed, in order to make more money, or avoid billing for procedures that they know will land a huge bill in the patient's lap.
  • Insurance companies are already hiring tech firms to put a stop to the practice, often with AI tools. Finlayson sees a future where basic adversarial attacks are used to fool the AI systems into continuing to accept fraudulent claims.
  • Despite this possibility, hospitals and the pharma industry are flying blind, he says. "Adversarial attacks aren't even on the map for them."

But, but, but: These hypotheticals are a bit far-fetched for Matthew Lungren, associate director of the Stanford Center for Artificial Intelligence in Medicine and Imaging.

  • "There are a lot of easier ways to defraud the system, frankly," he tells Axios.
  • But there is an urgent need, Lungren says, to test medical AI systems more rigorously before they're released into the world. Protecting against adversarial attacks is one of the ways experts should shore up algorithms before using them on patients.

Go deeper: Scientists call for rules on evaluating predictive AI in medicine

Go deeper

U.S. to buy 500 million more Pfizer doses to share with the world

A nurse fills a syringe with a dose of the Pfizer-BioNTech COVID-19 vaccine. Photo: Ben Hasty/MediaNews Group/Reading Eagle via Getty Images

The Biden administration is planning to purchase 500 million more Pfizer-BioNTech coronavirus vaccine doses to donate to the world, officials said in an op-ed Wednesday.

Why it matters: The move represents a big step toward making the U.S. a major global vaccine supplier just as China has ramped up exports of its Sinopharm, Sinovac and CanSino vaccines, which can be stored at normal refrigerator temperatures.

D.C.'s building boom grinds to a halt

Illustration: Brendan Lynch/Axios

The decades-long building boom that remade Washington D.C. is screeching to a halt, undone by broader construction trends and the legacy of the post-pandemic workplace.

Why it matters: Dizzying construction has reshaped the city, reinvigorated downtown and created bustling new communities. 

Facebook fights for its image

Illustration: Annelise Capossela/Axios

Facebook is ditching apologies and taking a more combative stance against its critics as it faces a new barrage of negative coverage and leaked internal reports.

Driving the news: As part of the new posture, Facebook started testing placing positive messages about itself in users' News Feeds last month, according to a New York Times story Tuesday.